ID: MRFR/HC/9493-CR | 136 Pages | Author: Rahul Gotadki | October 2022
The Ischemic Stroke Surgery Market is expected to reach USD 7.26 billion by 2035 and register a CAGR of 8.70% during the forecast period of 2022 to 2035. Ischemic stroke occurs when a blood clot blocks or narrows an artery leading to the brain. A blood clot often forms in arteries damaged by the buildup of plaques (atherosclerosis). It can occur in the carotid artery of the neck as well as other arteries. This is the most common type of stroke.
There are three forms of strokes that are a frequent condition for everyone across the world: transient ischemic attack, hemorrhagic stroke, and ischemic stroke. The global ischemic stroke surgery market is being driven by factors such as an increase in physical inactivity and sedentary lifestyles, the adoption and launch of technologically advanced products, and rising demand for minimally invasive procedures. Additionally, R&D activities and investments are expected to create lucrative growth opportunities for the market players in the forecast period. However, the lack of medical facilities in developing countries and the shortage of skilled professionals will restrain market growth over the projection period.
Impact of COVID-19
The pandemic has affected the business landscape for many organizations around the world. The supply chain in the ischemic stroke surgery devices market is the key to fulfilling customer demands. As a result of the pandemic, several countries had imposed import and export restrictions. This also affected the healthcare industry, as many countries are dependent on other countries for raw material supply and technology. Raw materials required for manufacturing ischemic stroke surgery devices faced a shortage during the first half of the pandemic. The COVID-19 pandemic has moderately disrupted the production and revenue of many companies. The pandemic had a slight negative impact on the global production of ischemic stroke surgery devices during the peak time of the pandemic in 2020. However, the majority of the players saw positive growth in the revenue of ischemic stroke surgery products in 2021 as supply chains were gradually restored and restrictions were reduced owing to the increasing percentage of vaccinated people and a global decline in infection rates.
Sedentary lifestyles have a significant impact on the global population's overall health. Rising sedentary behaviors, such as office work and increased indulgence in television and video devices, are having an impact on the overall human body mechanisms. For example, it decreases lipoprotein lipase activity, muscle glucose, protein transporter activity, and carbohydrate metabolism. Furthermore, it reduces cardiac output and systemic blood flow while activating the sympathetic nervous system, resulting in decreased insulin sensitivity and vascular function. As a result, there is a substantial risk of developing life-threatening diseases such as cardiovascular disease (CVD), diabetes mellitus (DM), obesity, atherosclerosis, hypercholesterolemia, and hypertension (HTN). After a prolonged period of time, these diseases can lead to an ischemic stroke.
There are several opportunities in the worldwide market for ischemic stroke surgery due to growing urbanization and an ageing population in the Asia-Pacific region. The crucial opportunity for the global ischemic stroke surgery market is R&D spending and activities. Globally, the healthcare sector is driving fast growth. The companies are raising funds and investing in modern technologies with strong management teams and capacity. The funds will also be used to support ongoing product development and to begin the commercialization of its technology. Hence, such investments by active players in the ischemic stroke surgery market are propelling the market forward.
Value Chain Analysis
The global ischemic stroke surgery market is growing at a significant rate owing to the rise in physical inactivity and sedentary lifestyles and the adoption and launch of technologically advanced products. The value chain analysis of the ischemic stroke market comprises major components starting from research and product development (R& D), followed by the manufacturing of the products, distribution & sales, and ends with post-sales services.
Ischemic Stroke Surgery Market Segment Overview
The global ischemic stroke surgery market has been divided based on type of surgery, product type and end user.
By Type of Surgery
Based on type of surgery, the market is segmented into thrombectomy, revascularization surgery, carotid endarterectomy, angioplasty, and others.
A surgery to remove a blood clot from a blood vessel is known as a thrombectomy (artery or vein). A blood clot, often referred to as a thrombus, can cut off the blood supply to the organs and/or extremities, which might be fatal or limb-threatening.
Revascularization is a surgical procedure that improves blood flow to the brain and reduces the risk of stroke and other types of brain tissue damage. Several medical diseases that restrict blood supply to the brain are treated with revascularization surgery. These diseases include carotid artery disease, moyamoya syndrome, and cerebral artery atherosclerosis. The risk of cerebral ischemia or an ischemic stroke increase with each of these disorders. Transient ischemic attacks (TIAs) may also result from the above-mentioned disorders.
A stroke may occur if the carotid arteries constrict significantly enough to obstruct blood flow or if a piece of plaque breaks off and obstructs blood flow to the brain. A transient ischemic attack, sometimes known as a "mini-stroke," is characterized by stroke-like symptoms that last for only a few minutes to a few hours. A procedure used to treat carotid artery disease is known as carotid endarterectomy.
Angioplasty is a minimally invasive endovascular procedure used to widen narrowed or obstructed arteries or veins. It is also known as balloon angioplasty and percutaneous transluminal angioplasty. During angioplasty, blood clots can break free and travel to the brain. In addition, angioplasty is frequently combined with the insertion of a small wire mesh tube known as a stent. The stent keeps the artery open and reduces the likelihood of it narrowing again.
Other surgical procedures used for removing the blood clots are mechanical embolectomy and decompressive craniectomy. Mechanical embolectomy is a cutting-edge, minimally invasive surgical procedure used to clear a blood vessel blockage. Mechanical embolectomy devices can be used routinely up to six hours (sometimes even 12 hours) after the onset of stroke symptoms, but each hour reduces the benefits while increasing the risks. Mechanical embolectomy is a different procedure than thrombectomy, as embolectomy is the removal of an embolus, and thrombectomy is the removal of a thrombus.
By Product Type
Based on product type, the global ischemic stroke surgery market has been categorized into catheters, aspiration system, guidewire, microcatheter, and others.
A catheter is a thin, flexible tube that allows fluids to be injected or removed from your body for a variety of surgical purposes. A catheter is inserted through an incision in the leg and up to the blocked artery, allowing the doctor to remove the blood clot.
An aspiration system is used for the removal of fluid or other tissues from the body to test them for diseases and disorders. Depending on the system purchased, a typical setup consists of a low-pressure vacuum pump, a collection bottle, and an interface with varying levels of control and precaution.
A guidewire is a thin, flexible medical wire that is inserted into the body to direct the placement of a relatively large instrument, such as a catheter, central venous line, or feeding tube. A guidewire's purpose is to gain access to blood vessels using a minimally invasive technique.
Microcatheters are small 0.70-1.30mm diameter catheters used in complex endovascular procedures for guidewire support, exchanges, accessing distal anatomy, crossing lesions, delivering therapeutic embolic, injecting contrast media, and performing other endovascular procedures.
Other products utilized in ischemic stroke surgeries include microsnare, stents, and retrieval devices. A numerous, particularly tiny retrieval loop for interventional (neuro-)radiology and cardiology is called a microsnare. The microsnare is designed for retrieval and manipulation of atraumatic foreign bodies in the coronary and peripheral cardiovascular systems, as well as the extracranial neurovascular anatomy.
By End User
Based on end user, the global ischemic stroke surgery market has been categorized into hospitals & clinics, ambulatory surgical centers, and others.
Global Ischemic Stroke Surgery Market Share (%), by End User, 2021
The rising prevalence of ischemic stroke cases at hospitals and clinics is driving global demand for ischemic stroke diagnostic and surgical procedures. Over the forecast period, the hospital segment is expected to hold the largest share. This is due to a well-developed healthcare infrastructure and an increase in healthcare expenditure. Furthermore, the increasing prevalence of ischemic strokes and other disorders is expected to boost this segment's growth.
Modern healthcare facilities known as ambulatory surgery centers, or ASCs, are devoted to providing same-day surgical care, including diagnostic and preventive procedures. Factors such as shorter hospital stays, lower treatment costs, and same-day surgeries, as well as improvements in ambulatory surgical center establishments in developing economies, are driving the segment growth.
Others segment involves comprehensive stroke center (CSC) and others. A comprehensive stroke center (CSC) is a facility or system that has the personnel, infrastructure, expertise, and programs needed to diagnose and treat stroke patients who require intensive medical and surgical care, specialized tests, or interventional therapies. Patients with large ischemic or hemorrhagic strokes, those with unusual etiologies or requiring specialized testing or therapies, and those requiring multispecialty management are examples of patients who might use and benefit from a CSC.
The global ischemic stroke surgery market, based on region, has been divided into North America, Europe, Asia-Pacific, and the Rest of the World.
Global Ischemic Stroke Surgery Market Share (%), by Region, 2021
Several market drivers are propelling the growth of the North American market, including an increase in the number of acute ischemic stroke patients and advanced and innovative technological diagnostics such as neurological computed tomography scans (CT) and magnetic resonance imaging scans (MRI). There is a high prevalence of both acute and chronic ischemic strokes, which is a major growth factor in North America. In addition, increasing geriatric population in the region is also one of the core drivers as senior citizens over the age of 75 are more likely to have ischemic strokes.
Sedentary lifestyles, physical inactivity, poor diet, smoking, and obesity have been identified as major risk factors for ischemic stroke in European countries. Another factor driving the growth of the ischemic stroke surgery market is the region's elderly population and improved survival rate. Several European countries are working on research projects to develop an innovative thrombectomy procedure to treat severe cerebral infarcts. For instance, the European Society of Minimally Invasive Neurological Therapy (ESMINT) collaborated with the European-funded research project Efficacy and safety of ThrombEctomy in Stroke with an extended time window: a randomized, controlled trial (TENSION). TENSION measures the safety and effectiveness of endovascular thrombectomy compared to best medical care alone in the treatment of acute ischemic stroke patients with extensive stroke lesions.
The Asia-Pacific region has a high incidence of chronic diseases that lead to ischemic strokes, such as diabetes, hypertension, cardiovascular disease, and hyperlipidemia. In addition, there is an increase in the elderly population and positive government initiatives. According to a December 2021 article published by Science Direct, the South Asian region accounts for more than 40% of the developing world's stroke burden and is the leading contributor to global stroke mortality. These factors are fueling the growth of the ischemic stroke surgery market in the region.
The rest of the world comprises the Middle East, Africa, and Latin America. Non-communicable diseases (NCDs) are present around the world, but sub-Saharan Africa (SSA) has the highest frequency of the diseases. Non-communicable diseases (NCDs) are the second most common cause of death in sub-Saharan Africa (SSA). The most common causes of NCD deaths are cardiovascular diseases (CVDs). Hence, there is a significant demand for ischemic stroke procedures, which is driving the market's expansion.
The global ischemic stroke surgery market is characterized by the presence of many global, regional, and local players. The increasing number of strategic initiatives, the increasing prevalence of ischemic stroke globally and technological innovations in diagnostic and surgical devices make the ischemic stroke surgery market lucrative. To expand their reach and optimize their operational costs, the major players focus on obtaining regulatory authorization from government agencies for their products and emphasize acquisitions and product launches to gain a substantial market share.
The prominent players in the global ischemic stroke surgery market are Stryker (US), Medtronic Plc (Ireland), Johnson & Johnson Services Inc. (US), Boston Scientific Corporation (US), Penumbra, Inc. (US), Abbott Laboratories (US), Koninklijke Philips N.V. (Netherlands), Imperative Care (US), and Phenox GmbH (Germany).
The study covers the existing short-term and long-term market effects, helping decision-makers to draught short-term and long-term plans for businesses by region. The report covers major regions in North America, Europe, Asia-Pacific, and the Rest of the World. The report analyzes market drivers, restraints, opportunities, Porter's Five Forces, Value Chain, and the impact of COVID-19 on the market.
Scope of the Report & Segmentation
Global Ischemic Stroke Surgery Market, by Type of Surgery
Global Ischemic Stroke Surgery Market, by Product Type
Global Ischemic Stroke Surgery Market, by End User
Global Ischemic Stroke Surgery Market, by Region
|Market Size||2035: USD 7,266.15 Million|
|Historical Data||2018 to 2020|
|Forecast Units||Value (USD Million)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||Type of Surgery, Product Type, End User and Region|
|Geographies Covered||North America, Europe, Asia-Pacific, Rest of the World|
|Key Vendors||Stryker (US), Medtronic PLC (Ireland), Johnson & Johnson Services Inc. (US), Boston Scientific Corporation (US), Penumbra, Inc. (US), Abbott Laboratories (US), Koninklijke Philips N.V. (Netherlands), Imperative Care (US), Abbott Laboratories (US), and Phenox GmbH (Germany)|
|Key Market Opportunities||R&D activities and investments|
|Key Market Drivers||• Rise in physical inactivity and sedentary lifestyles • Adoption and launch of technologically advanced products • Rising demand for minimally invasive procedures|
The Ischemic Stroke Surgery Market is anticipated to reach USD 7.26 billion by 2035 and register a CAGR of 8.70% during the forecast period of 2022 to 2035.
Stryker (US), Medtronic PLC (Ireland), Johnson & Johnson Services Inc. (US), Boston Scientific Corporation (US), Penumbra, Inc. (US), Abbott Laboratories (US), Koninklijke Philips N.V. (Netherlands), Imperative Care (US), Abbott Laboratories (US), and Phenox GmbH (Germany) are the key players in the market of Ischemic Stroke Surgery
North America is predicted to lead the market of Ischemic Stroke Surgery
Rise in physical inactivity and sedentary lifestyles and Adoption and launch of technologically advanced products are driving the market growth
Lack of medical facilities and Shortage of skilled professionals are the market deterrents.
Key Questions Answered
Why Choose Market Research Future?